Pepcid AC gelcaps
This article was originally published in The Tan Sheet
Executive Summary
FDA review of J&J/Merck's supplemental NDA for the new famotidine dosage form is expected to be completed by June 22. The application was designated "approvable" by the agency Sept. 30. The company launched Pepcid AC Chewables in October following FDA's Sept. 24 approval ("The Tan Sheet" Oct. 5, 1998, p. 22)